Tyler N Bennett

Array ( [id] => 4271697 [patent_doc_number] => 06307023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Gene encoding a polypeptide having pre-B cell growth-supporting ability' [patent_app_type] => 1 [patent_app_number] => 9/517739 [patent_app_country] => US [patent_app_date] => 2000-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9941 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/307/06307023.pdf [firstpage_image] =>[orig_patent_app_number] => 517739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404541 [patent_doc_number] => 06309637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Human microfibril-associated glycoprotein 4 splice variant' [patent_app_type] => 1 [patent_app_number] => 9/468702 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22019 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309637.pdf [firstpage_image] =>[orig_patent_app_number] => 468702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446001 [patent_doc_number] => 06368636 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Mesenchymal stem cells for prevention and treatment of immune responses in transplantation' [patent_app_type] => B1 [patent_app_number] => 09/427333 [patent_app_country] => US [patent_app_date] => 1999-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14507 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368636.pdf [firstpage_image] =>[orig_patent_app_number] => 09427333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493844 [patent_doc_number] => 06342344 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions' [patent_app_type] => B1 [patent_app_number] => 09/363677 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5587 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342344.pdf [firstpage_image] =>[orig_patent_app_number] => 09363677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419075 [patent_doc_number] => 06225071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Methods of screening for compounds which mimic galectin-1' [patent_app_type] => 1 [patent_app_number] => 9/346442 [patent_app_country] => US [patent_app_date] => 1999-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10314 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225071.pdf [firstpage_image] =>[orig_patent_app_number] => 346442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435606 [patent_doc_number] => 06355248 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent' [patent_app_type] => B1 [patent_app_number] => 09/334819 [patent_app_country] => US [patent_app_date] => 1999-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14224 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355248.pdf [firstpage_image] =>[orig_patent_app_number] => 09334819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408526 [patent_doc_number] => 06232441 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'PIGR-1, a member of immunoglobulin gene superfamily' [patent_app_type] => 1 [patent_app_number] => 9/300985 [patent_app_country] => US [patent_app_date] => 1999-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8981 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232441.pdf [firstpage_image] =>[orig_patent_app_number] => 300985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564677 [patent_doc_number] => 06338942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-01-15 [patent_title] => 'Selective expansion of target cell populations' [patent_app_type] => B2 [patent_app_number] => 09/290712 [patent_app_country] => US [patent_app_date] => 1999-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 9921 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/338/06338942.pdf [firstpage_image] =>[orig_patent_app_number] => 09290712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493368 [patent_doc_number] => 06403092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Immune response modulator alpha-2 macroglobulin complex' [patent_app_type] => B1 [patent_app_number] => 09/282826 [patent_app_country] => US [patent_app_date] => 1999-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19019 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403092.pdf [firstpage_image] =>[orig_patent_app_number] => 09282826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320206 [patent_doc_number] => 06328960 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Mesenchymal stem cells for prevention and treatment of immune responses in transplantation' [patent_app_type] => 1 [patent_app_number] => 9/267536 [patent_app_country] => US [patent_app_date] => 1999-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13410 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/328/06328960.pdf [firstpage_image] =>[orig_patent_app_number] => 267536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323366 [patent_doc_number] => 06329159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function' [patent_app_type] => 1 [patent_app_number] => 9/266464 [patent_app_country] => US [patent_app_date] => 1999-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 61 [patent_no_of_words] => 21088 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329159.pdf [firstpage_image] =>[orig_patent_app_number] => 266464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473884 [patent_doc_number] => 06387613 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Human short-chain dehydrogenase' [patent_app_type] => B1 [patent_app_number] => 09/249241 [patent_app_country] => US [patent_app_date] => 1999-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20724 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387613.pdf [firstpage_image] =>[orig_patent_app_number] => 09249241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355800 [patent_doc_number] => 06291651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Antibodies to a novel src-family kinase' [patent_app_type] => 1 [patent_app_number] => 9/228603 [patent_app_country] => US [patent_app_date] => 1999-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 24662 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291651.pdf [firstpage_image] =>[orig_patent_app_number] => 228603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943485 [patent_doc_number] => 05990087 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Human ena/VASP-like protein splice variant' [patent_app_type] => 1 [patent_app_number] => 9/227420 [patent_app_country] => US [patent_app_date] => 1999-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23087 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990087.pdf [firstpage_image] =>[orig_patent_app_number] => 227420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945914 [patent_doc_number] => 05998373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Carboxypeptidase inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/212167 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 20289 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998373.pdf [firstpage_image] =>[orig_patent_app_number] => 212167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945632 [patent_doc_number] => 05977072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'High affinity immunoglobulin E receptor-like protein' [patent_app_type] => 1 [patent_app_number] => 9/213389 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19871 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977072.pdf [firstpage_image] =>[orig_patent_app_number] => 213389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147103 [patent_doc_number] => 06063767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Human phospholipid binding proteins' [patent_app_type] => 1 [patent_app_number] => 9/208718 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22945 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063767.pdf [firstpage_image] =>[orig_patent_app_number] => 208718 [rel_patent_id] =>[rel_patent_doc_number] =>)